Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia
Purpose: To determine the safety, efficacy, and tolerability of combinations of pilocarpine (Pilo) and oxymetazoline (Oxy) ocular drops dosed once daily and identify the optimal concentration of each for the pharmacologic treatment of presbyopia. Design: Two concurrent Phase 2, multicenter, double-m...
Saved in:
Main Authors: | Francis W. Price, Jr., MD, Milton Hom, OD, Majid Moshirfar, MD, David Evans, OD, Haixia Liu, MD, PhD, Jeff Penzner, PharmD, Michael R. Robinson, MD, Sungwook Lee, PhD, David L. Wirta, MD |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f3ff05453a3a427e87ac7613d6ea841d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Presbyopia Treatments by Mechanism of Action: A New Classification System Based on a Review of the Literature
by: Chang DH, et al.
Published: (2021) -
FEATURES OF VISUAL PERCEPTION IN PATIENTS WITH PRESBYOPIA, DEPENDING ON THE TYPE OF INTRAOCULAR CORRECTION
by: A. G. Shchuko, et al.
Published: (2016) -
Maximum human objectively measured pharmacologically stimulated accommodative amplitude
by: Grzybowski A, et al.
Published: (2018) -
Characterization of mouse salivary polypeptide secretion after oral administration of pilocarpine
by: LÓPEZ-SOLÍS,REMIGIO, et al.
Published: (2001) -
Substantial outcome improvement using a refined pilocarpine mouse model of temporal lobe epilepsy
by: Alexandre Vigier, et al.
Published: (2021)